Cyclodextrin complexes for treatment improvement in infectious diseases

Julieta C. Imperiale, Alejandro D. Sosnik

Research output: Contribution to journalReview articlepeer-review

Abstract

Infectious diseases are a heterogeneous group of maladies that represent a serious burden to healthcare systems worldwide. Most of the available antimicrobial drugs display poor biopharmaceutical properties that compromise their effectiveness. Cyclodextrins (CDs) are cyclic oligosaccharides of glucopyranose formed by a variable number of repeating units that combine a hydrophilic surface with a hydrophobic cavity. The production of drug/CD complexes has become one of the most extensively investigated technology approaches to improve the stability, solubility, dissolution rate and bioavailability of drugs. The present work overviews the applications of CDs for the formulation of anti-infective agents along with the most relevant administration routes. Finally, an update on the complexes with CDs available on the market to treat infectious diseases is presented.

Original languageEnglish
Pages (from-to)1621-1641
Number of pages21
JournalNanomedicine
Volume10
Issue number10
DOIs
StatePublished - 1 May 2015

Keywords

  • cyclodextrins
  • drug/cyclodextrin complex
  • infectious diseases
  • low physical stability
  • poor aqueous solubility

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • General Materials Science

Fingerprint

Dive into the research topics of 'Cyclodextrin complexes for treatment improvement in infectious diseases'. Together they form a unique fingerprint.

Cite this